NYMANZO

Glaxo Group Limited

Application Filed: 2018-11-14

Trademark Application Details

Status

700

Live/Registered

REGISTERED

Research	OneLook Acronym Finder
Serial Number	88193823
Registration Number	5780875
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Merilee J. Arevalo
Attorney Docket Number	82759145
Law Office Assigned	L80
Employee Name	LOOK, JEFFREY J

Timeline

2018-11-14	Application Filed
2019-04-02	Published for Opposition
2019-06-18	Location: PUBLICATION AND ISSUE SECTION
2019-06-18	Status: Live/Registered
2019-06-18	Trademark Registered
2019-12-05	Transaction Date

Trademark Applicants & Owners

Owner:	Glaxo Group Limited
Entity Statement	private company limited by shares (prc)
Address	980 Great West Road Brentford, Middles TW89GS GB2
Legal Entity Type
Legal Entity State	GB2

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Merilee J. Arevalo
GSK
LBP, 5.5A
Five Moore Drive
Research Triangle Park NC 27709

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
GS0051	Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

GS0051

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2018-11-17	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-12-01	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2019-02-19	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-02-19	4 CNSA O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-03-13	5 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2019-04-02	6 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-04-02	7 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2019-06-18	8 R.PR A:Allowance for Publication
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2019-12-05	9 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2019-12-05	10 ARAA I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2022-11-08	11 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2022-11-08	12 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2022-11-08	13 TCCA I:Incoming Correspondence
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2023-10-06	14 COAR I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2023-10-06	15 CHAN I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2023-10-06	16 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2023-10-06	17 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2023-10-06	18 TCCA I:Incoming Correspondence
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED	2024-06-18	19 REM1 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.